Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Frequently Asked Questions (FAQ) Q: How long until I see results
Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
Safety Profile and Side Effects BPC-157 exhibits a favorable safety profile in available studies: Preclinical Toxicity : No lethal dose identified
In vivo models are more accessible than clinical models and can be used to screen a few hit therapeutics to determine safety and efficacy in whole system living organisms
"While supplements like weight-loss gummies claim to increase GLP-1 naturally, their effects are not comparable to prescription GLP-1 receptor agonists," notes Dr Misra-Sharp
